AstraZeneca/Bristol's Diabetes Drug Onglyza Cleared

AstraZeneca hints that drug could be priced lower than Merck's blockbuster Januvia.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet